Scientific Programme 2020

Wednesday 22rd January 2020

Moderator: Hans Eiskjaer + one young investigator

 

(20 min talk and 10 min discussion)

16.00–16.30

The burden of heart failure - differences in treatment in US vs. Europe

Martin Strueber
New Jersey, USA

16.30–17.00

ECMO in cardiogenic shock: How to select to improve outcomes?

Jan van der Linden
Stockholm, Sweden

17.00–17.30

Coffee break

17.30–18.00

Frailty phenotypes and mortality in lung transplantation

Selim Arcasoy
New York, USA

18.00–19.00

Fascinating Failures and Surprising Successes Session -
5 Case presentation sections (8 min Talk - 2 min Questions

Moderator: Hans Eiskjaer + one young investigator

18.00–18.10
Cool lung case

Selim Arcasoy
New York, USA

18.10–18.20
Acute West Nile virus 10 days post Heart Transplant

Rachel Zabner,
Los Angeles, USA

18.20–18.30
29-year survival after lung transplantation

Diana van Kessel,
Utrecht, NL

18.30–18.40
Awake ECMO bridge to Lung Transplantation

Harpreet Grewal,
Newark, USA

18.40–18.50
Durable MCS in patient with Adult Congenital Heart Disease

Fabrizio De Rita,
Newcastle, UK

18.50–19.00
When PAH risk stratification differs from clinical reality and in listing for lung transplantation?

Göran Rådegran,
Lund, SWE

 

Thursday 23rd January 2020

Moderator: Clive Lewis and Yaron Barac

 

FOCUS ON THE RIGHT VENTRICULE
(10 min talk & 10 min discussion)

16.00–16.20

RV failure post heart transplant: Mechanical support or medical therapy?

David Schibilsky
Tubingen, Germany

16.20–16.40

RV Dysfunction in Chronic Lung Failure

Glenn Westall
Melbourne, Australia

16.40–17.10

Business meeting

17.10–17.30

Coffee break (In meeting room)

17.30–17.50

Physiology and Mechanisms of RV failure in Pulmonary Hypertension

Tji Gan
Groeningen, Netherlands

LUNG TRANSPLANTATION

17.50–18.10

Cross matching for Lung Transplantation

Greg Snell
Melbourne, Australia

18.30–18.50

Lung Transplant Conversion

Jim Egan
Dublin, Ireland

19.00–19.30

WERNER ZUBER MEMORIAL LECTURE

Xtreme Everest: Cardiopulmonary physiology

Mike Grocott,
Southhampton, UK

 

Friday 24th January 2020

Moderator: Göran Dellgren + one young investigator

 

(20 min talk and 10 min discussion)

16.00–16.30

Pathogenesis and management of MCS Infections

Anton Peleg
Melbourne, UK

16.30–17.00

Wireless Durable LVADs: From Lab to Clinical Application

Stephan Scheuler
Newcastle, UK

17.00–17.30

Coffee break

17.30–18.00

Pro-Con Debate -
Results with TAH are superior to BiVAD in pateints with severe RV dysfunction (10 min talks and 5 min rebuttal)

Pro Michiel Morshuis,
Bad Oeyenhausen, GER
versus
Con Kristjan Karason,
Gothenburg, SWE

18.00–19.30

Young investigators Session (8 mins. Talk - 3 mins. Questions)

18.00–18.11
What's the correct temperature for heart preservation?

Vincent van Suylen
Groningen, Netherlands

18.11–18.22
Incidence, predictors and outcome of acute cellular rejection early and late after heart transplantation.

Carl Söderlund
Lund, Sweden

18.22–18.33
Early RHF post Tricuspid Valve Repair Concurrent with LVAD Implantation is not associated with Late RHF.

Yaron Barac
Tel Aviv, Israel

18.33–18.44
Micro and macrovascular cardiac allograft vasculopathy in heart transplant recipients related to 92 cardiovascular biomarkers evaluated by a novel proximity extension assay

Kamilla Bjerre
Aarhus, Denmark

18.44–18.55
Hemodynamic and functional adaption of the right ventricle during the first year after heart transplantation

Tor Clemmensen
Aarhus, Denmark

18.55–19.06
Variation in time to peak values for different lung function parameters after double lung transplantation

Hans Schultz
Copenhagen, Denmark

19.06–19.17
Using ECMO after paediatric heart transplantation–A single centre experience and impact of ECMO outcomes

Gaia Vigano
Newcastle, UK

19.17–19.30
The first 25 transplanted Ex Vivo lung perfusion cases in the Netherlands

Z L Zhang
Groningen, Netherlands